HR0196 101ST GENERAL ASSEMBLY

HR0196 LRB101 11554 MST 57474 r

HOUSE RESOLUTION

WHEREAS, Vaccines have reduced the burden of widespread and often fatal diseases, enabling individuals to lead longer and healthier lives, while reducing health care costs; and

WHEREAS, Healthy People 2020 maintains goals of increasing immunization rates and reducing preventable infectious diseases in the United States; and

WHEREAS, The Centers for Disease Control and Prevention (CDC), the American Academy of Pediatrics, and the Society for Adolescent Health and Medicine recommend that all adolescents aged 11 to 12 years get annual check-ups; and

WHEREAS, Safe and effective vaccines exist for the preteen adolescent population, such as those for meningococcal disease, human papillomavirus, influenza, tetanus, diphtheria, pertussis, measles, mumps, and rubella; and

WHEREAS, Babies, teens, and young adults have higher rates of meningococcal disease than people of other ages; and

WHEREAS, In 2016, the incidence of meningococcal disease in the United States was 0.12 per 100,000 people, and 10 to 15 out of every 100 people infected with meningococcal disease will die; and

WHEREAS, The Advisory Committee on Immunization Practices (ACIP) recommends that all adolescents aged 11 to 12 years be vaccinated with a meningococcal conjugate vaccine; and

WHEREAS, The CDC estimates that influenza has resulted in between 9.3 million to 49 million illnesses, 140,000 to 960,000 hospitalizations, and 12,000 to 79,000 deaths annually in the United States since 2010; and

WHEREAS, The ACIP recommends routine annual influenza vaccination for all individuals above the age of six months who do not have contraindications; and

WHEREAS, Of the 18,975 cases of Pertussis that were reported in the United States in 2018, 1,595 were among adolescents aged 7 to 10 years and 4,214 were among adolescents aged 11 to 19 years; and

WHEREAS, The ACIP recommends routine vaccination for tetanus, diphtheria, and pertussis; and

WHEREAS, The ACIP recommends that adolescents 11 and 12 years of age receive a single dose of the tetanus, diphtheria, and pertussis vaccination, and adolescents and young adults 13 and 18 years of age, who have not received the tetanus, diphtheria, and pertussis vaccination, receive one dose; and

WHEREAS, The CDC estimates that there was a total of 3,218 cases of acute hepatitis B in the United States in 2016 and an incidence rate of 1.0 cases per 100,000 people in the United States in the same year; and

WHEREAS, The ACIP recommends catch-up hepatitis B vaccination for adolescents aged 11-15 years using an alternative 2-dose schedule with at least 4 months between doses; and

WHEREAS, In 2018, the United States experienced 17 measles outbreaks, and the majority of people who got measles were unvaccinated; in 2016, the CDC reported a total of 6,366 cases of mumps in the United States; and

WHEREAS, The ACIP recommends vaccination against measles, mumps, and rubella for teens and adults at post-high school educational institutions, international travelers, healthcare professionals, women of childbearing age who are not pregnant, people who care for or are around immunocompromised people, and people living with HIV who are not showing signs of severe immunosuppression; and

WHEREAS, The CDC estimates that there are more than 3.5 million cases of varicella infection and 9,000 related hospitalizations annually in the United States; and

WHEREAS, The ACIP recommends that children and adolescents between the ages of 7 and 12 years, who have no evidence of immunity, receive a 2-dose series of the varicella vaccine 4 weeks to 3 months apart, and the ACIP recommends that adolescents over the age of 13 years receive 2 doses of the varicella vaccine 4 to 8 weeks apart; and

WHEREAS, The CDC estimates that there are 33,700 cases of human papillomavirus-associated cancers diagnosed annually in the United States, with 24,400 cases among women and 18,3000 cases among men; and

WHEREAS, The human papillomavirus vaccine offers long-lasting protection against human papillomavirus infection and therefore the disease caused by the infection; and

WHEREAS, The ACIP recommends routine vaccination against the human papillomavirus vaccine for all adolescents between the ages of 11 and 12 years and as early as 9 years; therefore, be it

RESOLVED, BY THE HOUSE OF REPRESENTATIVES OF THE ONE HUNDRED FIRST GENERAL ASSEMBLY OF THE STATE OF ILLINOIS, that the week of August 5, 2019 is declared "Adolescent Immunization Week" in Illinois to increase public awareness of the importance of preteens and adolescents receiving vaccines against meningococcal disease, human papillomavirus, influenza, tetanus, diphtheria, pertussis, measles, mumps, and rubella, and to promote outreach and education efforts concerning vaccination; and be it further

RESOLVED, That the Illinois Department of Public Health is urged to promote Adolescent Immunization Week by requesting health care practitioners discuss infectious diseases with preteen patients and their parents or guardians, and by adopting appropriate programs and initiatives to raise public awareness of the importance of preteen vaccination against meningococcal disease, human papillomavirus, influenza, tetanus, diphtheria, pertussis, measles, mumps, and rubella; and be it further

RESOLVED, That the Illinois Department of Public Health is urged to create and disseminate educational resources on meningococcal disease, human papillomavirus, influenza, tetanus, diphtheria, pertussis, measles, mumps, rubella, and available vaccinations, while coordinating with local health authorities to host annual health and immunization focused fairs to educate the residents of Illinois on vaccine-preventable diseases; and be it further

RESOLVED, That the Illinois Department of Public Health is urged to identify and coordinate with other agencies to ensure that informed and proper vaccine quality measures pertinent to adolescent vaccines are included in measurement frameworks and reporting programs; and be it further

RESOLVED, That a suitable copy of this resolution be delivered to the Illinois Department of Public Health.